Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tenaya Therapeutics Inc shares valued at $615 were sold by Higa Tomohiro on May 16 ’25. At $0.44 per share, Higa Tomohiro sold 1,390 shares. The insider’s holdings dropped to 98,300 shares worth approximately $52099.0 following the completion of this transaction.
Also, Tingley Whittemore sold 2,937 shares, netting a total of over 1,300 in proceeds. Following the sale of shares at $0.44 each, the insider now holds 171,856 shares.
Before that, Ali Faraz had sold 3,189 shares from its account. In a trade valued at $1,412, the Chief Executive Officer traded Tenaya Therapeutics Inc shares for $0.44 each. Upon closing the transaction, the insider’s holdings decreased to 3,189 shares, worth approximately $0.17 million.
As published in their initiating research note from William Blair on June 10, 2024, Tenaya Therapeutics Inc [TNYA] has been an Outperform. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in late November. As of June 15, 2022, H.C. Wainwright has initiated its “Buy” rating for TNYA.
Analyzing TNYA Stock Performance
During the last five days, there has been a surge of approximately 19.24%. Over the course of the year, Tenaya Therapeutics Inc shares have dropped approximately -63.17%. Shares of the company reached a 52-week high of $1.6300 on 01/07/25 and a 52-week low of $0.3600 on 05/13/25.
Support And Resistance Levels for Tenaya Therapeutics Inc (TNYA)
According to the 24-hour chart, there is a support level at 0.4959, which, if violated, would cause prices to drop to 0.4650. In the upper region, resistance lies at 0.5436. The next price resistance is at 0.5604. RSI (Relative Strength Index) is 61.01 on the 14-day chart, showing neutral technical sentiment.
